| Previous Close | 74.19 |
| Open | 75.43 |
| Bid | 75.02 x 100 |
| Ask | 75.03 x 500 |
| Day's Range | 74.65 - 75.99 |
| 52 Week Range | 63.76 - 82.10 |
| Volume | 10,713,400 |
| Avg. Volume | 8,568,701 |
| Market Cap | 97.91B |
| Beta | 0.96 |
| PE Ratio (TTM) | 7.92 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 2.08 (2.82%) |
| Ex-Dividend Date | 2017-06-14 |
| 1y Target Est | N/A |
- Editor's PickYahoo Finance•2 days ago
Facebook earnings, Fed announcement — What you need to know in markets on Wednesday
The Fed will be overshadowed on Wednesday by the continued parade of corporate earnings coming out this week.
- SmarterAnalyst•3 hours ago
Biotech’s Sell-Side Roundup: Cowen’s Take on Gilead Sciences, Inc. (GILD) and Celgene Corporation (CELG)
Gilead Sciences, Inc.
- InvestorPlace•5 hours ago
Gilead Sciences, Inc. (GILD) Stock Has Tremendous Potential Even Post-Rally
For the past few months, Gilead Sciences, Inc. (NASDAQ:GILD) could not fulfill the technical upside promise. Last night, GILD report earnings and the stock is spiking toward $76. Click to Enlarge Coming into the earnings, sentiment had also shifted in favor of better days to come from GILD stock, and I am one who likes to trade with the market sentiment.
